Details for Austria Supplementary Protection Certificate: 5/2022
Austria Supplementary Protection Certificate: 5/2022
| Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2383297 | 5/2022 | Austria | PRODUCT NAME: TAFASITAMAB; REGISTRATION NO/DATE: EU/1/21/1570 (MITTEILUNG) 20210901 | ⤷ Start Trial |
| >Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |
